Chrysin based pyrimidine-piperazine hybrids: design, synthesis, in vitro antimicrobial and in silico E. coli topoisomerase II DNA gyrase efficacy

Patel, Kajalben B.; Rajani, Dhanji P.; Ahmad, Iqrar; Patel, Harun; Patel, Hitesh D.; Kumari, Premlata

doi:10.1007/s11030-023-10663-1

Cited by 6 publications

(2 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The RMSD of the ligand was closely monitored to understand its dynamic changes within the binding site of the receptor. [41][42][43] Initially, there was noticeable fluctuation in the ligand RMSD, which is typical as the simulation system adapts to 2A). This stability suggests that the ligand had achieved a stable position within the receptor's active site.…”

Section: Simulationmentioning

confidence: 99%

Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide

Soni,

Patel,

Ahmad

et al. 2024

J Biochem & Molecular Tox

Self Cite

View full text Add to dashboard Cite

Isonicotinohydrazide is the first‐line medication in the prevention and treatment of tuberculosis. Antitubercular, antibacterial, antifungal, antiviral, anti‐inflammatory, antimalarial activity, anticancer, antineoplastic activity, and anti‐HIV activity are all demonstrated by drugs with a pyrimidine ring. The current study focuses on the synthesis of N‐(4‐(substituted‐phenyl)‐6‐(substituted‐aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoylhydrazinyl) acetamide from isonicotinohydrazide. Newly synthesized compounds were characterized by spectral studies (IR, 1H‐NMR, 13C‐NMR, and mass spectroscopy). They were screened for their antituberculosis, antimalarial, and antiprotozoal activities and compared with standard drugs. Molecular docking of isonicotinohydrazide‐bearing pyrimidine motifs was also done for some of the active compounds.

show abstract

Section: Simulationmentioning

confidence: 99%

Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide

Soni,

Patel,

Ahmad

et al. 2024

J Biochem & Molecular Tox

Self Cite

View full text Add to dashboard Cite

show abstract

“…Kumari et al sought to develop an antibacterial agent incorporating pyrimidines by targeting the enzyme DNA gyrase which is a bacterial topoisomerase II [ 20 ]. DNA gyrase is responsible for DNA replication, transcription, repair and decatenation in the bacteria.…”

Section: Pyrimidine-based Drugs For Treatment Of Infectionsmentioning

confidence: 99%

Recent Advances in Pyrimidine-Based Drugs

Nammalwar,

Bunce

2024

Pharmaceuticals

View full text Add to dashboard Cite

Pyrimidines have become an increasingly important core structure in many drug molecules over the past 60 years. This article surveys recent areas in which pyrimidines have had a major impact in drug discovery therapeutics, including anti-infectives, anticancer, immunology, immuno-oncology, neurological disorders, chronic pain, and diabetes mellitus. The article presents the synthesis of the medicinal agents and highlights the role of the biological target with respect to the disease model. Additionally, the biological potency, ADME properties and pharmacokinetics/pharmacodynamics (if available) are discussed. This survey attempts to demonstrate the versatility of pyrimidine-based drugs, not only for their potency and affinity but also for the improved medicinal chemistry properties of pyrimidine as a bioisostere for phenyl and other aromatic π systems. It is hoped that this article will provide insight to researchers considering the pyrimidine scaffold as a chemotype in future drug candidates in order to counteract medical conditions previously deemed untreatable.

show abstract

Development of novel thiazole-based hybrids as DNA gyrase inhibitors: design, synthesis, in silico and in vitro antibacterial evaluation

Vaghasiya,

Mendapara,

Ahmad

et al. 2024

J IRAN CHEM SOC

View full text Add to dashboard Cite

Chrysin based pyrimidine-piperazine hybrids: design, synthesis, in vitro antimicrobial and in silico E. coli topoisomerase II DNA gyrase efficacy

Cited by 6 publications

References 32 publications

Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide

Synthesis, biological evaluation, and In silico molecular docking of N‐(4‐(4‐substitutedphenyl)‐6‐(substituted aryl) pyrimidin‐2‐yl)‐2‐(2‐isonicotinoyl hydrazinyl) acetamide

Recent Advances in Pyrimidine-Based Drugs

Development of novel thiazole-based hybrids as DNA gyrase inhibitors: design, synthesis, in silico and in vitro antibacterial evaluation

Contact Info

Product

Resources

About